Transmedics Group Inc [NASDAQ: TMDX] loss -16.09% on the last trading session, reaching $71.44 price per share at the time.
If compared to the average trading volume of 1.64M shares, TMDX reached a trading volume of 4632770 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Here is what top equities market gurus are saying about Transmedics Group Inc [TMDX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TMDX shares is $115.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TMDX stock is a recommendation set at 1.56. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Transmedics Group Inc shares, keeping their opinion on the stock as Hold, with their previous recommendation back on November 22, 2024. While these analysts kept the previous recommendation, Oppenheimer dropped their target price from $200 to $125. The new note on the price target was released on October 29, 2024, representing the official price target for Transmedics Group Inc stock. Previously, the target price had yet another drop from $208 to $109, while Needham kept a Buy rating on TMDX stock.
The Average True Range (ATR) for Transmedics Group Inc is set at 6.19, with the Price to Sales ratio for TMDX stock in the period of the last 12 months amounting to 5.98. The Price to Book ratio for the last quarter was 11.42, with the Price to Cash per share for the same quarter was set at 9.84.
Trading performance analysis for TMDX stock
Transmedics Group Inc [TMDX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.09. With this latest performance, TMDX shares dropped by -13.30% in over the last four-week period, additionally sinking by -46.88% over the last 6 months – not to mention a drop of -4.31% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TMDX stock in for the last two-week period is set at 31.42, with the RSI for the last a single of trading hit 30.54, and the three-weeks RSI is set at 32.06 for Transmedics Group Inc [TMDX]. The present Moving Average for the last 50 days of trading for this stock 109.89, while it was recorded at 82.20 for the last single week of trading, and 121.96 for the last 200 days.
Transmedics Group Inc [TMDX]: A deeper dive into fundamental analysis
Transmedics Group Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.33 and a Current Ratio set at 8.20.
An analysis of Institutional ownership at Transmedics Group Inc [TMDX]
There are presently around $112.70%, or 116.40%% of TMDX stock, in the hands of institutional investors. The top three institutional holders of TMDX stocks are: FMR LLC with ownership of 4.49 million shares, which is approximately 13.7063%. BLACKROCK INC., holding 2.65 million shares of the stock with an approximate value of $$398.47 million in TMDX stocks shares; and BLACKROCK INC., currently with $$380.53 million in TMDX stock with ownership which is approximately 7.7118%.
